tiprankstipranks
Advertisement
Advertisement
Pharmaron Says New Manufacturing Deal Is Within Ordinary Course of Business
PremiumCompany AnnouncementsPharmaron Says New Manufacturing Deal Is Within Ordinary Course of Business
1M ago
Pharmaron Raises HK$1.32 Billion via H-Share Placement to Fund Capacity Expansion
Premium
Company Announcements
Pharmaron Raises HK$1.32 Billion via H-Share Placement to Fund Capacity Expansion
3M ago
Pharmaron Beijing to Raise Capital via HK$22.82-per-Share H-Share Placement
Premium
Company Announcements
Pharmaron Beijing to Raise Capital via HK$22.82-per-Share H-Share Placement
3M ago
Pharmaron Beijing Announces 2025 Extraordinary General Meeting
PremiumCompany AnnouncementsPharmaron Beijing Announces 2025 Extraordinary General Meeting
5M ago
Pharmaron Expands CRO Market Presence with Biortus Acquisition
Premium
Company Announcements
Pharmaron Expands CRO Market Presence with Biortus Acquisition
5M ago
Pharmaron Beijing Co., Ltd. Strengthens Corporate Governance with New Audit Committee
Premium
Company Announcements
Pharmaron Beijing Co., Ltd. Strengthens Corporate Governance with New Audit Committee
6M ago
17Q1 Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings17Q1 Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6M ago
Pharmaron Beijing Schedules Board Meeting to Review Q3 Results
Premium
Company Announcements
Pharmaron Beijing Schedules Board Meeting to Review Q3 Results
6M ago
Pharmaron Shaoxing Passes U.S. FDA Inspection, Boosting Global CDMO Credentials
Premium
Company Announcements
Pharmaron Shaoxing Passes U.S. FDA Inspection, Boosting Global CDMO Credentials
7M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―